Remove Biopharma Remove Networking Remove Pharma Remove Pharmaceutical products
article thumbnail

Pharma’s climate change vulnerability and opportunity

pharmaphorum

As one of the world’s biggest contributors to climate change, pharma is morally obliged to adapt its processes and operations – and doing so will open up new opportunities for growth. Pharma’s reliance on global supply chains and its need for vast quantities of water make it particularly vulnerable to climate change. Responsibility .

article thumbnail

Practical advice for Early Scientific Advice (ESA) in HTA submissions

pharmaphorum

In recent years, the biopharma market has become progressively complex. As a result, payers are feeling increased pressure to make the right decisions based on the perceived value of each product. HTA agencies can assist biopharma companies at the early stages of development to ensure they are meeting the expectations of payers.